2m 2m 2m 2m 2m 2m 2m
COOPER CO (COO)
NASDAQ
$66.15+$0.72 (+1.11%)
Price as of Jun 23, 2026 5:03 PM EDT- $12.8BMarket Cap
- -5.90%1-Year Change
- Medical Instruments & SuppliesIndustry
COOPER CO (COO)
$66.15+$0.72 (+1.11%)
Annual
Quarterly
10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 4.1B +5.06% | 3.9B +8.41% | 3.6B +8.61% | 3.3B +13.20% | |
Cost of Revenue | 1.4B +8.51% | 1.3B +5.21% | 1.2B +5.69% | 1.2B +20.91% | |
Gross Profit | 2.7B +3.33% | 2.6B +10.09% | 2.4B +10.20% | 2.1B +9.40% | |
Sales and Marketing Expense | 1.6B +6.14% | 1.5B +2.16% | 1.5B +11.85% | 1.3B +10.82% | |
Research and Development Expense | -172.2M +11.03% | -155.1M +12.88% | -137.4M +24.57% | -110.3M +18.99% | |
Depreciation and Amortization Expense | 377.4M +0.61% | 375.1M +2.01% | 367.7M +6.24% | 346.1M +11.90% | |
Total Operating Expenses | 1.4B +8.51% | 1.3B +5.21% | 1.2B +5.69% | 1.2B +20.91% | |
Operating Profit | 682.9M -3.23% | 705.7M +32.38% | 533.1M +5.02% | 507.6M +0.36% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -105.3M +83.77% | -57.3M +148.05% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -105.3M +83.77% | -57.3M +148.05% | |
Total Nonoperating Income and Expense | -16.4M +80.22% | -9.1M -38.93% | -14.9M -159.60% | 25.0M +184.09% | |
Income before Taxes | 566.5M -2.71% | 582.3M +41.03% | 412.9M -13.13% | 475.3M -3.30% | |
Income Taxes | 191.6M +0.84% | 190.0M +60.07% | 118.7M +32.63% | 89.5M +103.65% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 374.9M -4.44% | 392.3M +33.34% | 294.2M -23.74% | 385.8M -86.90% | |
Net Income from Continuing Operations Applicable to Common | 566.5M -2.71% | 582.3M +41.03% | 412.9M -13.13% | 475.3M -3.30% | |
Basic EPS and Net Income | 1.88 -4.57% | 1.97 -66.84% | 5.94 -24.14% | 7.83 -86.91% | |
Diluted EPS and Net Income | 1.87 -4.59% | 1.96 -66.84% | 5.91 -23.84% | 7.76 -86.88% | |
Basic Weighted Average Shares | 199.1M +0.10% | 198.9M +301.82% | 49.5M +0.41% | 49.3M +0.20% | |
Diluted Weighted Average Shares | 200.0M -0.20% | 200.4M +302.41% | 49.8M +0.20% | 49.7M -0.20% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 110.6M +2.79% | 107.6M -10.93% | 120.8M -12.59% | 138.2M +44.11% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 110.6M +2.79% | 107.6M -10.93% | 120.8M -12.59% | 138.2M +44.11% | |
Total Current Assets | 2.1B +7.94% | 2.0B +14.46% | 1.7B +11.17% | 1.5B +4.66% | |
Accumulated Depreciation | 1.8B +7.66% | 1.7B +9.22% | 1.6B +11.97% | 1.4B +6.05% | |
Property and Plant and Equipment and Net | 2.1B +11.73% | 1.9B +14.14% | 1.6B +13.94% | 1.4B +6.33% | |
Total Long-Term Assets | 689.2M +4.33% | 660.6M +3.69% | 637.1M +8.37% | 587.9M +307.70% | |
Total Assets | 12.4B +0.65% | 12.3B +5.63% | 11.7B +1.45% | 11.5B +19.63% | |
Income Taxes Payable | 100.8M -34.33% | 153.5M -19.93% | 191.7M -27.14% | 263.1M +60.72% | |
Total Short-Term Debt | 47.8M +43.54% | 33.3M -26.65% | 45.4M -89.00% | 412.6M +397.71% | |
Total Current Liabilities | 1.1B +8.80% | 1.0B +5.55% | 969.0M -24.31% | 1.3B +74.87% | |
Total Long-Term Debt | 2.5B -3.64% | 2.6B +1.05% | 2.5B +7.36% | 2.4B +68.38% | |
Total Long-Term Liabilities | 282.8M -9.24% | 311.6M +30.27% | 239.2M -51.98% | 498.1M -70.28% | |
Total Liabilities | 4.2B -1.79% | 4.2B +3.01% | 4.1B -4.86% | 4.3B +62.06% | |
Retained Earnings | 7.6B +5.16% | 7.3B +5.71% | 6.9B +4.42% | 6.6B +6.17% | |
Total Stockholders Equity | 8.2B +1.92% | 8.1B +7.05% | 7.6B +5.24% | 7.2B +3.35% | |
Total Shares Outstanding | 195.9M -1.85% | 199.6M +303.23% | 49.5M +0.41% | 49.3M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 796.1M +12.24% | 709.3M +16.76% | 607.5M -12.26% | 692.4M -6.26% | |
Capital Expenditures | 362.4M -13.96% | 421.2M +7.31% | 392.5M +62.19% | 242.0M +12.87% | |
Cash from Investing Activities | -372.9M -51.23% | -764.6M +70.29% | -449.0M -75.48% | -1.8B +306.66% | |
Dividends Paid | 0 N/A | 0 -100.00% | 3.0M 0.00% | 3.0M 0.00% | |
Cash from Financing Activities | -425.9M -1,186.48% | 39.2M +122.54% | -173.9M -114.57% | 1.2B +483.33% | |
Financials Ratio | |||||
Gross Margin | 65.54% -1.65% | 66.64% +1.54% | 65.62% +1.47% | 64.67% -3.36% | |
Operating Margin | 16.69% -7.89% | 18.12% +22.11% | 14.84% -3.30% | 15.34% -11.35% | |
Return on Assets | 3.03% -7.28% | 3.27% +28.77% | 2.54% -30.50% | 3.66% -89.85% | |
Return on Equity | 4.59% -8.46% | 5.02% +25.59% | 4.00% -26.90% | 5.47% -90.01% | |
Revenue Growth | 5.06% -39.87% | 8.41% -2.30% | 8.61% -34.81% | 13.20% -34.71% | |
Current Ratio | 1.89 -0.79% | 1.91 +8.45% | 1.76 +46.87% | 1.20 -40.15% | |
Cash Ratio | 0.10 -5.51% | 0.11 -15.64% | 0.12 +15.46% | 0.11 -17.56% | |
Debt-to-Equity Ratio | 0.30 -4.85% | 0.32 -6.08% | 0.34 -11.66% | 0.39 +80.76% | |
Debt-to-Assets Ratio | 0.20 -3.67% | 0.21 -4.81% | 0.22 -8.36% | 0.24 +56.17% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow